Drug combination reduces colon cancer risk (Reuters)

[riky]

Drug combination reduces colon cancer risk
    (Reuters)

 


Reuters - Combining a low dose of a targeted
cancer-fighter with an anti-inflammatory drug reduces the risk
of recurring colorectal polyps, an early sign of colon cancer,
by as much as 95 percent, researchers said on Monday.


You are not allowed to view links. Register or Login/news.yahoo.com/s/nm/20080414/hl_nm/cancer_colon_prevention_dc